Schizophrenia is a serious and chronic mental illness that interferes with clear thinking, emotional responses, and social connections. Symptoms include hallucinations, delusions, a lack of emotions, disconnect, cognitive issues, and disorganized thought. Schizophrenia is often associated with imaginary voices, nonsensical speech, or a lack of movement or talking. Studies have shown CBD has antipsychotic properties and can reduce psychotic symptoms.
While CBD may be beneficial in reducing psychotic symptoms, it is important to understand that some studies have found strains high in THC has been associated with an increased risk of developing psychotic disorders. Animal and human studies have found CBD, on the other hand, has antipsychotic properties and is safe and well tolerated. One study found CBD significantly lowers psychotic symptoms and can ameliorate positive and negative symptoms of schizophrenia. Some researchers theorize CBD's activation of the CB2 receptors account for its ability to produce antipsychotic effects. Some psychotic disorders are associated with an altered immune system, which is regulated by the endocannabinoid system and modulated by CB2 receptors. One study found CBD inhibits the degradation of anandamide, an endocannabinoid inversely associated with psychotic symptoms.
This information has been adapted from Medical Marijuana Inc. and approved by our Chief Medical Officer.